A Real-Time Interpretable Ai Model for the Cholangioscopic Diagnosis of Malignant Biliary Stricture

Xiang Zhang,Dehua Tang,Jindong Zhou,Muhan Ni,Peng Yan,Zhenyu Zhang,Tao Yu,Qiang Zhan,Yonghua Shen,Lin Zhou,Ruhua Zheng,Xiaoping Zou,Bin Zhang,Wu-Jun Li,Lei Wang
DOI: https://doi.org/10.2139/ssrn.4270316
2022-01-01
SSRN Electronic Journal
Abstract:Background: It is crucial to accurately determine malignant biliary strictures (MBSs) for early curative treatment. Therefore, an effective and accessible modality is needed to facilitate the diagnosis of MBSs. The study aimed to develop a real-time interpretable artificial intelligent (AI) system to predict MBSs under digital single-operator cholangioscopy (DSOC).Methods: A novel interpretable AI system called MBSDeiT was developed, consisting of two models to identify qualified images and then predict MBS in real time. The overall efficiency of MBSDeiT was validated at the image level on internal, external, prospective testing datasets and subgroups analyses, and at the video level on the prospective test datasets, and compared with that of endoscopists. The association between AI predictions and endoscopic features was evaluated to increase the interpretability.Findings: MBSDeiT can first automatically select qualified DSOC images with an AUC of 0.904 and 0.921–0.927 on the internal testing dataset and the external testing datasets, and then identify MBSs with an AUC of 0.971 on the internal testing dataset, an AUC of 0.978–0.999 on the external testing datasets, and an AUC of 0.976 on the prospective testing dataset, respectively. MBSDeiT accurately identified 92.3% MBS in prospective testing videos. Subgroups analyses confirmed the stability and robustness of MBSDeiT. MBSDeiT achieved superior performance to that of expert and novice endoscopists. The AI predictions were significantly associated with four endoscopic features [including mass (OR 25.17, 95% CI 8.73–72.61); friability (70.70, 16.89–296.03); raised intraductal lesion (10.94, 5.68–21.04); and abnormal vessels (103.08, 13.94–762.09)] under DSOC, which is consistent with the endoscopists’ predictions.Interpretation: The findings suggest that MBSDeiT could be a promising approach for the accurate diagnosis of MBS under DSOC.Funding Information: The project is funded by Jiangsu Provincial Health Commission (M20200034), and the key project of medical science and technology development of Nanjing Municipal Health Commission (ZKX21032).Declaration of Interests: All the authors declare that they have no competing interests.Ethics Approval Statement: The study protocols were approved by the Medical Ethics Committee of Nanjing Drum Tower Hospital (no. 2022-420-01). Informed consent for this study was collected except for those patients whose data were retrospectively collected and anonymized.
What problem does this paper attempt to address?